CIK 0001175151
- Non-accelerated filer
- Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980373793
- Phone
- +1 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 10,000 shares at $5.98 ($59,779)
- 4 Open-market sale Director sold 10,000 shares at $6.29 ($62,852)
- 4 Open-market sale Director sold 13,205 shares at an average $7.33 ($96,781)
- 4 Open-market sale Director sold 10,000 shares at $5.78 ($57,782)
- 4 Open-market sale Director sold 10,000 shares at $6.29 ($62,883)
- 4 Open-market sale Director sold 10,000 shares at $6.30 ($63,000)
- 4 Open-market sale Director sold 10,000 shares at $6.32 ($63,247)
- 4 Open-market sale Director sold 10,000 shares at $6.08 ($60,823)
- 4 Open-market sale Director sold 10,000 shares at $6.00 ($59,996)
- 4 Open-market sale Chief Operating Officer sold 4,000 shares at $7.50 ($30,000)
- 4 Grant or award Director acquired 55,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 55,000 shares (grant or award)
- 4 Grant or award Director acquired 55,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 130,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 125,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 55,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 110,000 shares (grant or award)
Page 13 of 20 · 395 filings